Recent News

• 03.07.2025 - D - Notice of Exempt Offering of Securities
• 03.06.2025 - S-3 - Registration statement under Securities Act of 1933
• 03.04.2025 - GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit
• 02.26.2025 - 8-K - Current report
• 02.25.2025 - GT Biopharma Announces Exercise of Warrants
• 02.25.2025 - GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement
• 02.24.2025 - RW - Registration Withdrawal Request
• 02.21.2025 - 10-K - Annual report pursuant to Section 13 and 15(d)
• 02.07.2025 - S-1/A - General form of registration statement for all companies including face-amount certificate companies
• 01.27.2025 - S-1/A - General form of registration statement for all companies including face-amount certificate companies

Recent Filings

• 03.07.2025 - D Notice of Exempt Offering of Securities
• 03.06.2025 - S-3 Registration statement under Securities Act of 1933
• 02.26.2025 - 8-K Current report
• 02.24.2025 - RW Registration Withdrawal Request
• 02.21.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.07.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
• 01.27.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
• 01.27.2025 - 8-K Current report